Archive for the ‘comorbitities’ Category
COVID-19, vaccination, and psoriasis: the latest in what you need to know
Despite our best hopes, COVID is still with us, and now vaccination news and debates confront us wherever we turn, from the internet to the local convenience store. For people with psoriasis and/or psoriatic arthritis, it raises many questions, as we try to balance potential risks from the coronavirus with Continue Reading…
COVID vaccine hesitancy in psoriasis patients not necessary, experts say
A study reviewed social media posts of psoriasis and/or psoriatic arthritis patients in the US and four European countries to learn the top reasons for COVID vaccine hesitancy among those who are hesitant and using biologics to treat their psoriatic disease. The most commonly cited concerns, it turns out, have Continue Reading…
New patient registry PsoProtect for those battling both psoriasis and COVID-19/coronavirus could help provide treatment insights to both ailments
Scientists and physicians in the UK, working with an international coalition of experts and organizations, have launched a web-based registry that will gather health information on people with psoriasis who develop confirmed or suspected COVID-19/coronavirus. The results, if enough doctors participate, could provide important information in the treatment of both Continue Reading…
Do I need to worry about links between psoriasis and Alzheimer’s disease?
You may have seen the headlines: “Psoriasis tied to higher Alzheimer’s disease risk.” Great. Just another thing to worry about thanks to psoriasis, right? But when you dig into the research, you realize it’s mostly just the usual media hype: there’s no need to panic the next time you misplace Continue Reading…
Coronavirus, COVID-19, and psoriasis: what you need to know
We are sorry, this page was moved and updated here: COVID-19, vaccination, and psoriasis: the latest in what you need to know [Last updated 10-28-2021]
Opioid use “substantial” among people with moderate to severe psoriasis
A recent study looked at a database of privately insured people that included about 9,000 psoriasis patients, of whom just over 2,000 were identified as having moderate to severe psoriasis. It found that about 25% of those 2,000 received opioids, compared to 16% of otherwise-comparable people without psoriasis. The figure Continue Reading…
